Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Brain Markers of Gliosis in Inflammatory Bowel Disease

FY 2019-20

Summary
"About 1% of Canadians have inflammatory bowel disease (IBD). Inflammation is the redness you may see around a scrape that is the body's response to injury or infection, and in IBD, the inflammation is overly active and harms the gut. However, IBD is more than a disease in the gut, it is an illness that affects the brain too since clinical depression occurs three to five times more often in those with IBD than in the general population. Unfortunately, we know little about the brain effects of IBD and as a result there haven't been treatments designed for clinical depression in IBD, which this proposal intends to address.We think that brain inflammation may be an important aspect of IBD. We think that the inflammation in the gut spreads to the brain, but this has never been studied in IBD. Previously, we used new brain scanning methods to show that inflammation occurs in the brain in clinical depression and it is believed that inflammation in the brain contributes to symptoms of clinical depression. To date, one participant with IBD showed about a 200% increase in inflammation on the brain scan measure.In our study, we will compare measures of brain inflammation between people with and without IBD. If results demonstrate higher levels in people with the disease, brain inflammation would be the first disease aspect shown to be common to both IBD and depression. In this case, reduction of inflammation in the brain may be a beneficial method for treating depression in IBD patients. Currently, there are medications available that target brain inflammation in other illnesses that are not used in IBD. Such medications could be tested for effects on brain inflammation in IBD and may become new cures for clinical depression in IBD."
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428718
Name
Braga Joeffre N
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Brain Markers of Gliosis in Inflammatory Bowel Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Depression; Gliosis; Inflammatory Bowel Disease; Major Depressive Episodes; Monoamine Oxidase B; Neuroimaging; Neuroinflammation; Positron Emission Tomography; Translocator Protein
Abstract
"About 1% of Canadians have inflammatory bowel disease (IBD). Inflammation is the redness you may see around a scrape that is the body's response to injury or infection, and in IBD, the inflammation is overly active and harms the gut. However, IBD is more than a disease in the gut, it is an illness that affects the brain too since clinical depression occurs three to five times more often in those with IBD than in the general population. Unfortunately, we know little about the brain effects of IBD and as a result there haven't been treatments designed for clinical depression in IBD, which this proposal intends to address.We think that brain inflammation may be an important aspect of IBD. We think that the inflammation in the gut spreads to the brain, but this has never been studied in IBD. Previously, we used new brain scanning methods to show that inflammation occurs in the brain in clinical depression and it is believed that inflammation in the brain contributes to symptoms of clinical depression. To date, one participant with IBD showed about a 200% increase in inflammation on the brain scan measure.In our study, we will compare measures of brain inflammation between people with and without IBD. If results demonstrate higher levels in people with the disease, brain inflammation would be the first disease aspect shown to be common to both IBD and depression. In this case, reduction of inflammation in the brain may be a beneficial method for treating depression in IBD patients. Currently, there are medications available that target brain inflammation in other illnesses that are not used in IBD. Such medications could be tested for effects on brain inflammation in IBD and may become new cures for clinical depression in IBD."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Braga, Joeffre N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~